Hemoglobin Glycation Index Is Novel Risk Factor for Incident CKD
By Elana Gotkine HealthDay Reporter
TUESDAY, Nov. 21, 2023 -- Hemoglobin glycation index (HGI) is a novel risk factor for incident chronic kidney disease (CKD) in the general population, according to a study published online Nov. 1 in the Journal of Clinical Endocrinology & Metabolism.
Yasuto Nakasone, M.D., from the Aizawa Hospital in Matsumoto, Japan, and colleagues examined the impact of HGI as a predictor for incident CKD in the general population in a study using data from 23,467 CKD-free individuals followed for a mean of 5.1 years.
The researchers found that CKD developed in 2,540 individuals, and following low estimated glomerular filtration rate (eGFR), HGI was the second most robust predictor for CKD. The hazard ratio of HGI for CKD was 1.293 after adjustment for 11 covariates, including age, systolic blood pressure, and eGFR. The population attributable risk for HGI was 4.2 percent for CKD. In a subgroup of 708 individuals who were propensity score matched in a 1:1 ratio for nine covariates, HGI was significantly increased in individuals with CKD (median, −0.208 versus −0.284).
"Up to now, we have had only limited tools to predict future CKD for individuals who do not suffer from conventional risk factors, such as diabetes and hypertension," the authors write. "From this point of view, the 4.2 percent is not a small figure, because the denominator is the apparently healthy general population."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Planetary Health Diet Index Linked to Lower Total, Cause-Specific Mortality
MONDAY, June 10, 2024 -- A higher Planetary Health Diet Index (PHDI) is associated with a lower risk for total and cause-specific mortality, according to a study published online...
Prevalence of Iron Deficiency Varies With Different Definitions
MONDAY, June 10, 2024 -- The prevalence of iron deficiency varies significantly with three different definitions, according to a study published online June 7 in JAMA Network...
AI Blood-Based Lung Cancer Screening Test Developed for Fragmentome
MONDAY, June 10, 2024 -- A novel blood-based lung cancer screening test has been developed and validated using genome-wide sequencing to analyze cell-free DNA (cfDNA)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.